Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

First Hip and Knee Surgeries With ARVIS Augmented Reality Navigation System Completed

Insight Medical Systems reports they have completed the first clinical cases with its ARVIS® wearable augmented reality navigation system in conjunction with DJO’s EMPOWR™ implants. Seven surgeons across the country navigated over 30 total hip and total knee arthroplasties.

“I am so impressed with the accuracy and simplicity of ARVIS and can’t wait to see this technology grow. Having experienced the ups and downs of robotics, Augmented Reality has an endless future improving outcomes in joint arthroplasty in a cost-effective way!” – Robert Limoni, M.D.

“ARVIS was surprisingly easy to incorporate into our surgical workflow. I found it precise and accurate without the tremendous cost and inefficiencies that robotics has introduced to our specialty. Robotics and navigation, as we know it today, will quickly be replaced by this more sophisticated technology.” – Michael Nett, M.D.

This milestone not only emphasizes the value of ARVIS in clinical use, but also the adaptability of this technology to a range of clinical settings. In the last two weeks, ARVIS was used at an orthopedic specialty hospital, community hospitals, large research hospitals, and an ambulatory surgical center (ASC). This list includes sites where the use of computer-assisted surgery is standard, but also facilities that have historically not had access to navigation technology.

“We believe technology should be an integral part of orthopedic surgery, but its benefits shouldn’t be limited to a handful of hospitals that can afford million-dollar robots. It should be accessible to smaller community hospitals and ASC’s where an increasing proportion of elective surgeries are being performed.” – Nick van der Walt, CEO, Insight Medical Systems.

With its proprietary surgical augmented reality eyepiece, ARVIS was designed to be streamlined and cost-effective, making it accessible to any facility where orthopedic surgery is being conducted.

“ARVIS is exciting because it’s computerized navigation that uses the principles of minimalization, accuracy, and currently available equipment (helmets) with minimal footprint in the OR. The navigation camera moves from a large stationary apparatus to be the surgeon. This is the next step we were looking for.” – Ayal Segal, M.D.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy